Trial intelligence / Profile preview

Metformin and Muscle in Insulin-resistant Older Veterans (M&M)

NCT01804049Phase 2Completed

Sponsor
VA Office of Research & Development
Start
Apr 2014
Primary completion
Aug 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of liquid metformin (Aspargo Labs) in Sarcopenia, sponsored by VA Office of Research & Development. Started Apr 2014; status: completed.

02

Drugs

liquid metformin (Aspargo Labs)
03

Conditions

Sarcopenia

Beyond the preview

Go deeper on NCT01804049.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01804049.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call